| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,737 |
5,331 |
$2.14M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,143 |
6,755 |
$1.67M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
20,355 |
19,633 |
$1.37M |
| 80053 |
Comprehensive metabolic panel |
8,094 |
7,406 |
$112K |
| 70450 |
Computed tomography, head or brain; without contrast material |
967 |
920 |
$109K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,917 |
3,383 |
$97K |
| 71045 |
Radiologic examination, chest; single view |
3,507 |
3,235 |
$93K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,481 |
8,575 |
$80K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,954 |
2,564 |
$77K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,098 |
1,031 |
$67K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,981 |
1,748 |
$65K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,017 |
2,881 |
$58K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,365 |
3,270 |
$50K |
| 81025 |
|
5,498 |
5,220 |
$44K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
286 |
271 |
$43K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,682 |
1,603 |
$39K |
| 59025 |
Fetal non-stress test |
589 |
525 |
$38K |
| 87428 |
|
933 |
905 |
$36K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
678 |
630 |
$31K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,247 |
3,048 |
$29K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,435 |
2,298 |
$26K |
| 81001 |
|
6,359 |
5,958 |
$24K |
| 84484 |
|
2,346 |
1,807 |
$24K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,574 |
2,469 |
$24K |
| G0378 |
Hospital observation service, per hour |
606 |
445 |
$22K |
| 87070 |
|
2,223 |
2,166 |
$22K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
413 |
398 |
$20K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,296 |
1,184 |
$18K |
| 83880 |
|
563 |
525 |
$18K |
| 83690 |
|
2,583 |
2,407 |
$17K |
| 76801 |
|
140 |
136 |
$16K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
138 |
135 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,038 |
828 |
$10K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,171 |
1,878 |
$6K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
57 |
54 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
574 |
498 |
$6K |
| 84702 |
|
308 |
273 |
$5K |
| 87420 |
|
252 |
249 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
702 |
531 |
$4K |
| 81003 |
|
1,844 |
1,751 |
$4K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
17 |
16 |
$4K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
518 |
503 |
$3K |
| 87088 |
|
462 |
415 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
8,391 |
7,345 |
$3K |
| 83605 |
|
198 |
163 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,053 |
644 |
$2K |
| 85610 |
|
689 |
646 |
$2K |
| 87186 |
|
213 |
181 |
$2K |
| 82550 |
|
257 |
247 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
16 |
15 |
$2K |
| 87040 |
|
133 |
66 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
176 |
132 |
$1K |
| 85730 |
|
195 |
186 |
$883.20 |
| 82947 |
|
88 |
67 |
$848.60 |
| 86901 |
|
210 |
196 |
$611.74 |
| 86900 |
|
210 |
196 |
$609.13 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
97 |
87 |
$577.17 |
| 85027 |
|
97 |
81 |
$543.61 |
| 80320 |
|
40 |
37 |
$491.17 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,119 |
984 |
$489.72 |
| 73630 |
|
14 |
12 |
$458.13 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
274 |
237 |
$257.57 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
154 |
112 |
$221.29 |
| 82948 |
|
16 |
12 |
$163.59 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
124 |
117 |
$105.96 |
| 85007 |
|
44 |
40 |
$83.57 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
327 |
272 |
$38.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
22 |
14 |
$14.93 |
| 82962 |
|
512 |
256 |
$7.96 |
| J3490 |
Unclassified drugs |
12 |
12 |
$0.00 |